Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy
Authors
Keywords
Skeletal muscles, Computed axial tomography, Sarcopenia, Cancer treatment, Follicular lymphoma, Inflammation, Multivariate analysis, Muscle analysis
Journal
PLoS One
Volume 10, Issue 6, Pages e0127589
Publisher
Public Library of Science (PLoS)
Online
2015-06-02
DOI
10.1371/journal.pone.0127589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
- (2013) Sami Antoun et al. CANCER
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
- (2013) Mathias J Rummel et al. LANCET
- Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL
- (2012) C. Muller et al. BLOOD
- Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response
- (2012) U. Jager et al. HAEMATOLOGICA
- Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
- (2011) Michael S. Sabel et al. ANNALS OF SURGICAL ONCOLOGY
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Markers of Inflammation Are Heritable and Associated with Subcutaneous and Ectopic Skeletal Muscle Adiposity in African Ancestry Families
- (2011) Iva Miljkovic et al. Metabolic Syndrome and Related Disorders
- Epidemiology of myosteatosis
- (2010) Iva Miljkovic et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy*
- (2010) Sari Riihijärvi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
- (2010) Sami Antoun et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
- (2010) Gilles Salles et al. LANCET
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
- (2009) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now